.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
De novo lipogenesis (DNL) represents the metabolic conversion of carbohydrates into fatty acids for energy storage. Scientists recently analyzed how the regulator ChREBP influences lipid metabolism and longevity in unique mouse models. Furthermore, they found that reducing DNL in the liver significantly improves metabolic outcomes. Conversely, increasing this same process in brown adipose tissue (BAT) appears to promote health. Consequently, the balance of these pathways determines the aging trajectory of the organism.
The study utilized several slow-aging mouse models, including Ames and Snell dwarfs. Specifically, researchers observed a sharp decrease in lipogenic enzymes like FASN and ACC1 in the livers of these mice. In contrast, they identified a significant increase in these markers within the brown adipose tissue. This tissue-specific modulation serves as a shared trait across all five long-lived strains. Therefore, shifting lipid production away from the liver and toward BAT may be a key mechanism for life extension.
Additionally, ChREBP acts as a master switch for whole-body energy balance. High hepatic ChREBP activity often leads to insulin resistance and unwanted glucose production. However, in BAT, ChREBP facilitates the regulation of uncoupling protein 1 (UCP1). This protein is essential for thermogenesis and metabolic efficiency. Moreover, these findings suggest that targeting tissue-specific DNL could offer new therapeutic avenues for age-related metabolic disorders. Finally, clinicians should monitor these pathways to better understand metabolic aging in human patients.
ChREBP acts as a primary regulator for fat synthesis. Its activity in brown adipose tissue promotes healthy metabolism and longevity, whereas high levels in the liver can cause insulin resistance and metabolic dysfunction.
Brown adipose tissue helps regulate energy expenditure and thermogenesis. Increased activity in this tissue is a hallmark of long-lived mouse models and contributes to better metabolic health during the aging process.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always consult a qualified healthcare provider for personal medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Hager M et al. ChREBP-mediated regulation of lipid metabolism in liver and brown adipose tissue of long-lived mice. Geroscience. 2026 Apr 23. doi: 10.1007/s11357-026-02263-2. PMID: 42020920.
Herman MA et al. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature. 2012;484(7394):333-338.
Jang YH et al. ChREBP plays a pivotal role in the nutrient-mediated regulation of metabolic gene expression in brown adipose tissue. Life Sci. 2024;351:122843.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study explores how ChREBP regulates lipid metabolism in liver and brown adipose tissue, identifying a metabolic signature for longevity in slow-aging mice....
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
